{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:24:55Z","timestamp":1762521895679},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.gastrohep.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T21:54:06Z","timestamp":1460498046000},"page":"584-589","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Triple terapia 10 d\u00edas con esomeprazol 40 mg\/12 h vs. cu\u00e1druple concomitante sin bismuto como tratamiento de primera l\u00ednea de la infecci\u00f3n por Helicobacter pylori"],"prefix":"10.1016","volume":"39","author":[{"given":"Ana","family":"Campillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edurne","family":"Amorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Ostiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Kutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"LaIglesia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2016.03.002_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00042737-199701000-00002","article-title":"Current European concepts in the management of Helicobacter pylori infection \u2014 The Maastricht Consensus Report","volume":"9","author":"Malfertheiner","year":"1997","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.gastrohep.2013.02.006","article-title":"Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007-2012)","volume":"36","author":"Molina-Infante","year":"2013","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0105","first-page":"203","article-title":"Eficacia de las pautas m\u00e1s habituales para erradicar Helicobacter pylori en el \u00e1rea de Tudela (Navarra). Comunicaci\u00f3n en la XXV reuni\u00f3n anual de la AEG","volume":"35","author":"Campillo","year":"2012","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori \u2014 The Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.gastrohep.2013.01.011","article-title":"III Spanish Consensus Conference on Helicobacter pylori infection","volume":"36","author":"Gisbert","year":"2013","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0120","first-page":"236","article-title":"Resistencia de Helicobacter pylori a diversos antibi\u00f3ticos: estudio multic\u00e9ntrico espa\u00f1ol","volume":"34","author":"Perez-Trallero","year":"2011","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1523-5378.2012.00947.x","article-title":"Non-bismuth quadruple (concomitant) therapy: Empirical and tailored efficacy versus standard triple therapy for clarithromycin-resistant strains","volume":"17","author":"Molina-Infante","year":"2012","journal-title":"Helicobacter."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/gutjnl-2013-304820","article-title":"Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice","volume":"63","author":"McNicholl","year":"2014","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/hel.12231","article-title":"Antimicrobial susceptibility guided therapy versus empirical concomitant therapy for eradication of Helicobacter pylori in a region with high rate of clarithromicyn resistance","volume":"21","author":"Cosme","year":"2016","journal-title":"Helicobacter."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0140","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/jac\/dkv089","article-title":"First-line eradication rates comparing two shortened non-bismuth quadruple regimens against Helicobacter pylori: An open-label, randomized, multicentre clinical trial","volume":"70","author":"Cuadrado","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0145","first-page":"242","article-title":"Tratamiento cu\u00e1druple sin bismuto \u00abconcomitante\u00bb en la erradicaci\u00f3n del Helicobacter pylori: r\u00e9gimen est\u00e1ndar frente a optimizado (14 d\u00edas, dosis altas de IBP) en la pr\u00e1ctica cl\u00ednica. Comunicaci\u00f3n en la XVIII reuni\u00f3n anual de la AEG","volume":"38","author":"McNicholl","year":"2015","journal-title":"Gastroenterol Hepatolol."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.gastro.2013.03.050","article-title":"Optimized non bismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance","volume":"145","author":"Molina-Infante","year":"2013","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/apt.13069","article-title":"Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study","volume":"41","author":"Molina-Infante","year":"2015","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2012.05211.x","article-title":"Meta-analysis: Esomeprazole and rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection","volume":"36","author":"McNicholl","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cgh.2013.05.028","article-title":"Rational Helicobacter pylori therapy: Evidence based medicine rather than medicine based evidence (revision 2)","volume":"12","author":"Graham","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0170","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.3748\/wjg.v20.i30.10338","article-title":"Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance","volume":"20","author":"Molina-Infante","year":"2014","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000435949","article-title":"Prevalece of primary resistance of Helicobacter pylori to clarithromycin and levofloxacin in southern Spain","volume":"92","author":"Navarro-Jarabo","year":"2015","journal-title":"Digestion."},{"key":"10.1016\/j.gastrohep.2016.03.002_bib0180","first-page":"604","article-title":"14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: A randomized trial","volume":"34","author":"Greenberg","year":"2011","journal-title":"Lancet."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570516300139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570516300139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T11:52:50Z","timestamp":1536839570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570516300139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0210570516300139"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2016.03.002","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple terapia 10 d\u00edas con esomeprazol 40 mg\/12 h vs. cu\u00e1druple concomitante sin bismuto como tratamiento de primera l\u00ednea de la infecci\u00f3n por Helicobacter pylori","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U., AEEH y AEG. All rights reserved.","name":"copyright","label":"Copyright"}]}}